REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bioproec S.A. (Ecuador)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Health and Personal Care Stores
Full name: Bioproec S.A. Profile Updated: February 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Bioproec S.A. is a company based in Ecuador, with its head office in Quito. It operates in the Pharmacies and Drug Stores industry. Bioproec S.A. was incorporated on November 24, 2014. Bioproec S.A. currently employs 7 (2024) people. In 2024, the company reported a net sales revenue drop of 11.4%. A growth of 35.34% was recorded in its total assets. The net profit margin of Bioproec S.A. increased by 5.86% in 2024.

Headquarters
Av. Republica del Salvador N34-461, Cariari Bldg. , Floor 703
Quito; Pichincha;

Contact Details: Purchase the Bioproec S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Bioproec S.A. report to view the information.
Registered Capital:
Purchase the Bioproec S.A. report to view the information.
Financial Auditors:
Purchase the Bioproec S.A. report to view the information.
Incorporation Date:
November 24, 2014
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Bioproec S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-11.4%▼
Total operating revenue
-11.4%▼
Operating profit (EBIT)
396.91%▲
EBITDA
372.21%▲
Net Profit (Loss) for the Period
341.77%▲
Total assets
35.34%▲
Total equity
24.22%▲
Operating Profit Margin (ROS)
10.63%▲
Net Profit Margin
5.86%▲
Return on Equity (ROE)
12.78%▲
Debt to Equity Ratio
-56.49%▼
Quick Ratio
0.15%▲
Cash Ratio
0.03%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo